Results · Apr-Jun 2026 · filed 13 Aug 2026
Brooks Laboratories Q1 FY27 results
Sales fell 10% to ₹23 crore from ₹25.5 crore in Apr-Jun 2025.
Operating profit fell 40% to ₹1.9 crore, an operating margin of 8.1% (down 4.1 points from a year ago).
Net profit turned into a loss of ₹1.8 crore, from a profit of ₹9.6 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +14%, swings to a loss.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 23.0 | 25.5 | −10% |
| Operating profit (EBITDA) | 1.9 | 3.1 | −40% |
| Operating margin | 8.1% | 12.3% | −4.1 pts |
| Net profit | -1.8 | 9.6 | swings to a loss |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 17 Aug 2026Intimation Of Record Date, E-Voting Dates And Book Closure Date
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 13 Aug 2026Results - Financial Results For June 30, 2026.
- 13 Aug 2026Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, 13Th August, 2026
- 13 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 12 Aug 2026Letter To The Shareholders - Annual Report For The FY 2025-26.
- 12 Aug 2026Shareholder Meeting- AGM On 3Rd September 2026.
- 12 Aug 2026Reg. 34 (1) Annual Report.
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.